ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2014 ACR/ARHP Annual Meeting

November 14-19, 2014. Boston, MA.

View by Title View Sessions
  • 2014 Rheumatology Research Foundation Edmond L. Dubois, MD Memorial Lectureship
  • ACR Late-breaking Abstract Poster Presentations
  • ACR Late-breaking Abstracts Session
  • ACR Plenary Session I: Discovery 2014
  • ACR Plenary Session II: Discovery 2014
  • ACR Plenary Session III: Discovery 2014
  • ACR/ARHP Combined Abstract Session: Epidemiology and Public Health
  • ACR/ARHP Combined Abstract Session: Pediatric Rheumatology
  • ACR/ARHP Combined Abstract Session: Rehabilitation
  • Antiphospholipid Syndrome
  • B cell Biology and Targets in Autoimmune Disease
  • B cell Biology and Targets in Autoimmune Disease: Rheumatoid Arthritis and Related Diseases
  • B cell Biology and Targets in Autoimmune Disease: Systemic Lupus Erythematosus and Related Diseases
  • Biology and Pathology of Bone and Joint I: Bone Remodeling in Inflammation and Arthritis
  • Biology and Pathology of Bone and Joint II: Cartilage Biology and Synovial Activation
  • Biology and Pathology of Bone and Joint: Cartilage, Synovium and Osteoarthritis
  • Biology and Pathology of Bone and Joint: Osteoclasts, Osteoblasts and Bone Remodeling
  • Clinical Practice/Patient Care
  • Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis
  • Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis I
  • Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis II
  • Education
  • Education (ACR)
  • Education (ARHP): Education/Community Programs
  • Epidemiology and Public Health (ACR): Rheumatoid Arthritis Pathogenesis and Treatment
  • Epidemiology and Public Health (ACR): Rheumatoid Arthritis and Systemic Lupus Erythematosus Outcomes
  • Epidemiology and Public Health (ARHP)
  • Epidemiology and Public Health (ARHP): Epidemiology and Public Health
  • Epidemiology and Public Health I: Drug and Vaccine Safety
  • Epidemiology and Public Health II: Osteoarthritis, Sedentary Behavior and more
  • Epidemiology and Public Health III: Gout and Systemic Lupus Erythematosus
  • Epidemiology and Public Health IV: Rheumatoid Arthritis Pathogenesis
  • Epidemiology and Public Health: Osteoporosis, Non-Inflammatory Arthritis and More
  • Epidemiology/Public Health
  • Exemplary Abstracts
  • Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes I: Research Perspectives
  • Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes II: Clinical Perspectives
  • Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes: Clinical Focus
  • Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes: Research Focus
  • Genetics, Genomics and Proteomics
  • Genetics, Genomics and Proteomics I
  • Genetics, Genomics and Proteomics I: Epigenetic Mechanisms in Autoimmunity
  • Genetics, Genomics and Proteomics II
  • Genetics, Genomics and Proteomics II: Genetics of Autoimmunity
  • Health Disparities/Social Determinants of Health
  • Health Services Research
  • Health Services Research (ARHP): Health Services Research
  • Health Services Research: Improving Clinical Practice
  • Health Services Research: Risk Assessment and Outcomes of Rheumatic Disease
  • Imaging of Rheumatic Diseases: Magnetic Resonance Imaging (MRI)
  • Imaging of Rheumatic Diseases: Ultrasound
  • Imaging of Rheumatic Diseases: Various Imaging Techniques
  • Imaging of Rheumatic Diseases: X-ray, MRI and CT
  • Infections, Infection-related Biomarkers and Impact of Biologic Therapies
  • Innate Immunity and Rheumatic Disease
  • Innate Immunity and Rheumatic Disease: Mediators, Cells and Receptors
  • Innate Immunity and Rheumatic Disease: Signaling Mechanisms
  • Innovations in Rheumatologic Care
  • Metabolic and Crystal Arthropathies I: Clinical Aspects
  • Metabolic and Crystal Arthropathies II: Mechanisms of Disease
  • Metabolic and Crystal Arthropathies: Clinical Aspects
  • Metabolic and Crystal Arthropathies: Mechanisms of Disease
  • Miscellaneous Rheumatic and Inflammatory Diseases
  • Miscellaneous Rheumatic and Inflammatory Diseases/Innate Immunity and Rheumatic Disease: Assessing Outcomes of Infections in Rheumatic Disease
  • Muscle Biology, Myositis and Myopathies
  • Muscle Biology, Myositis and Myopathies: Immunological Aspects of Inflammatory Myopathy
  • Muscle Biology, Myositis and Myopathies: Myositis Autoantibodies and Disease Phenotype
  • Orthopedics, Low Back Pain and Rehabilitation
  • Osteoarthritis
  • Osteoarthritis - Clinical Aspects I: Imaging in Osteoarthritis
  • Osteoarthritis - Clinical Aspects II: Osteoarthritis Risk Factors and Therapies
  • Osteoarthritis - Clinical Aspects: Epidemiology and Pathogenesis
  • Osteoarthritis - Clinical Aspects: Imaging and Biomechanics
  • Osteoarthritis - Clinical Aspects: Therapeutics
  • Osteoporosis and Metabolic Bone Disease - Clinical Aspects and Pathogenesis: Clinical Osteoporosis: Treatment and Safety
  • Osteoporosis and Metabolic Bone Disease - Clinical Aspects and Pathogenesis: Osteoporosis: Pathogenesis, Epidemiology and Diagnosis
  • Osteoporosis and Metabolic Bone Disease - Clinical Aspects and Pathogenesis: Osteoporosis: Treatment, Safety, and Long Term Outcomes
  • Pain: Basic and Clinical Aspects
  • Pain: Basic and Clinical Aspects I
  • Pain: Basic and Clinical Aspects II/Orthopedics, Low Back Pain and Rehabilitation
  • Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis
  • Pediatric Rheumatology - Clinical and Therapeutic Aspects: Miscellaneous Pediatric Rheumatic Diseases
  • Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Lupus, Scleroderma and Myositis (ACR)
  • Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Systemic Lupus Erythematosus
  • Pediatric Rheumatology - Clinical and Therapeutic Aspects: Systemic Juvenile Idiopathic Arthritis, Spondyloarthropathy and Miscellaneous Pediatric Rheumatic Diseases
  • Pediatric Rheumatology - Pathogenesis and Genetics
  • Pediatric Rheumatology – Clinical and Therapeutic Aspects (ARHP): Pediatrics
  • Psychology/Social Sciences (ARHP)
  • Quality Measures and Quality of Care
  • Rehabilitation Sciences (ARHP)
  • Research Methodology (ARHP)
  • Rheumatoid Arthritis - Animal Models
  • Rheumatoid Arthritis - Animal Models I
  • Rheumatoid Arthritis - Animal Models II
  • Rheumatoid Arthritis - Clinical Aspects (ACR): Comorbidities, Treatment Outcomes and Mortality
  • Rheumatoid Arthritis - Clinical Aspects (ACR): Impact of Various Interventions and Therapeutic Approaches
  • Rheumatoid Arthritis - Clinical Aspects (ARHP): Clinical Practice/Patient Care
  • Rheumatoid Arthritis - Clinical Aspects I: Cardiovascular Disease Risk
  • Rheumatoid Arthritis - Clinical Aspects II: Remission and De-escalation of Therapy
  • Rheumatoid Arthritis - Clinical Aspects III: Malignancies, Vaccinations, Pregnancy and Surgery
  • Rheumatoid Arthritis - Clinical Aspects IV: Promising Biomarkers
  • Rheumatoid Arthritis - Clinical Aspects V: Mortality and Other Outcomes
  • Rheumatoid Arthritis - Clinical Aspects VI: Impact of Treatment and Other Interventions
  • Rheumatoid Arthritis - Clinical Aspects VII: New Aspects of Monitoring Disease
  • Rheumatoid Arthritis - Clinical Aspects: Novel Biomarkers and Other Measurements of Disease Activity
  • Rheumatoid Arthritis - Human Etiology and Pathogenesis
  • Rheumatoid Arthritis - Human Etiology and Pathogenesis I: Mechanisms of Joint Damage
  • Rheumatoid Arthritis - Human Etiology and Pathogenesis II: Citrullination, Autoantibodies and Genes
  • Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy I: Safety of Biologics and Small Molecules in Rheumatoid Arthritis - Malignancy and Infection
  • Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy II: Novel Therapies in Rheumatoid Arthritis - Early in Development
  • Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy III: Innovative Therapeutic Strategies in Rheumatoid Arthritis
  • Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy IV: Safety of Biologics and Small Molecules in Rheumatoid Arthritis - Cardiovascular and Other Systems
  • Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy V: Novel Therapies in Rheumatoid Arthritis - Late in Development
  • Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy VI: Biomarkers and Predictors of Rheumatoid Arthritis Disease Response and Outcomes
  • Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy: Novel therapies, Biosimilars, Strategies and Mechanisms in Rheumatoid Arthritis
  • Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy: Safety of Biologics and Small Molecules in Rheumatoid Arthritis
  • Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy: Therapeutic Strategies, Biomarkers and Predictors of Outcomes in Rheumatoid Arthritis
  • Sjogren's Syndrome I: Clinical Perspectives
  • Sjogren's Syndrome II: Insights into Pathophysiology
  • Sjogren's Syndrome: Clinical Science
  • Sjogren's Syndrome: Pathophysiology
  • Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment I
  • Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment II
  • Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment III
  • Spondyloarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology
  • Spondyloarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology: From Genes to Cytokines
  • Spondyloarthropathies and Psoriatic Arthritis I - Novel Treatments Axial Spondyloarthritis
  • Spondyloarthropathies and Psoriatic Arthritis II - Novel Treatments Psoriatic Arthritis
  • Spondyloarthropathies and Psoriatic Arthritis III - Clinical Aspects Psoriatic Arthritis
  • Spondyloarthropathies and Psoriatic Arthritis IV - Clinical Aspects Axial Spondyloarthritis
  • Spondyloarthropathies and Psoriatic Arthritis V - Clinical Aspects and Treatment
  • Spondyloarthropathies and Psoriatic Arthritis VI - Imaging and Biomarkers
  • Systemic Lupus Erythematosus - Animal Models
  • Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Biomarker, Translational and Nephritis Studies
  • Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Biomarkers in Systemic Lupus Erythematosus
  • Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Cardiovascular Disease and Pregnancy
  • Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Central Nervous System and Other Clinical Aspects
  • Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Complications of Systemic Lupus Erythematosus
  • Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Epidemiology, Women's Health, Cardiovascular and CNS
  • Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Lupus Nephritis
  • Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Novel Therapies for Systemic Lupus Erythematosus
  • Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Treatment and Management Studies
  • Systemic Lupus Erythematosus - Human Etiology and Pathogenesis I: Pathways of Inflammation/Injury
  • Systemic Lupus Erythematosus - Human Etiology and Pathogenesis II: Pathogenic Targets, Genetic Variants and Apoptosis
  • Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: Autoimmune Disease Transition, Disease Subsets and Prediction of Flares, Cytokines and Autoantibodies
  • Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: T and B Cell Signaling and Genetic Variants
  • Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics I: Systemic Sclerosis, Advances in Therapy
  • Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics II: Approaches to Cardiac and Vascular Manifestations in Systemic Sclerosis
  • Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics III: Updates in Predictors and Outcomes in Systemic Sclerosis
  • Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics: Determinants of Disease, Classification and Response
  • Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics: Systemic Sclerosis Measures and Outcomes
  • Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics: Systemic Sclerosis, Diagnostic and Therapeutic Aspects
  • Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics
  • Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics I
  • Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics II
  • T cell Biology and Targets in Autoimmune Disease
  • T cell Biology in Lupus, Vasculitis, Myositis and Other Autoimmunity
  • T cell Biology in Rheumatoid Arthritis and Other Arthritis
  • Vasculitis
  • Vasculitis I
  • Vasculitis II
  • Vasculitis III
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences